Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 12/29/2025

Asymmetric Intrauterine Growth Restriction Causes and Characteristics

Etiology and Pathophysiology

  • The American College of Obstetricians and Gynecologists notes that placental insufficiency is the most common cause of asymmetric IUGR, accounting for 25-30% of all fetal growth restriction cases 1
  • Placental insufficiency due to suboptimal perfusion of the maternal-placental circulation is the leading cause, responsible for 25-30% of all FGR cases 1
  • The American Journal of Obstetrics and Gynecology reports that chromosomal disorders and congenital malformations account for approximately 20% of FGR cases 1

Clinical Presentation and Diagnosis

  • The American College of Radiology suggests that earlier in gestation, chromosomal anomalies, syndromes, and viral infections are more common etiologies 2, 3
  • Later in gestation, placental insufficiency predominates, especially related to hypertension and maternal vascular disease 2, 3
  • Asymmetric FGR with "head-sparing" is characteristically more common in late-onset cases, where placental insufficiency leads to preferential blood flow redistribution to protect the fetal brain at the expense of abdominal/somatic growth 2, 3

Evaluation and Management

  • The American College of Obstetricians and Gynecologists recommends that maternal history of hypertensive disorders is a key association with late-onset asymmetric FGR 4, 5
  • A detailed fetal structural survey should have been performed prenatally, as approximately 10% of fetuses with FGR have congenital anomalies 2

Fetal Abnormalities Contributing to Intrauterine Growth Restriction (IUGR)

Epidemiology

  • Chromosomal disorders and congenital malformations together account for ≈ 20 % of all IUGR cases, making them the second‑most common cause after placental insufficiency. 6

Diagnostic Testing

Early‑Onset IUGR (< 32 weeks)

  • Chromosomal microarray analysis (CMA) is recommended for unexplained isolated IUGR diagnosed before 32 weeks (GRADE 1C). This test provides a 4–10 % incremental diagnostic yield over standard karyotyping. 6
  • When amniocentesis is performed for unexplained IUGR, polymerase chain reaction (PCR) testing for cytomegalovirus (CMV) should be offered. 6

Infectious Screening

  • Do not screen for toxoplasmosis, rubella, or herpes in the absence of specific risk factors, as routine testing adds no clinical benefit. 6

Management & Surveillance

  • After an IUGR diagnosis, serial umbilical artery Doppler assessments should be performed to monitor for fetal deterioration. 6

Resource Utilization

  • Ordering unnecessary infectious disease screening (toxoplasmosis, rubella, herpes) without risk factors wastes resources and may delay appropriate management. 6